BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 250 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $855,000 | -39.5% | 7,208 | -29.8% | 0.27% | -38.5% |
| Q4 2021 | $1,414,000 | +1.4% | 10,265 | +2.2% | 0.44% | -12.0% |
| Q3 2021 | $1,394,000 | +13.8% | 10,046 | -20.4% | 0.50% | +13.9% |
| Q2 2021 | $1,225,000 | +40.8% | 12,621 | -0.8% | 0.44% | +27.2% |
| Q1 2021 | $870,000 | -21.3% | 12,726 | -1.3% | 0.35% | -24.8% |
| Q4 2020 | $1,105,000 | +33.9% | 12,889 | +1.6% | 0.46% | +18.9% |
| Q3 2020 | $825,000 | -10.0% | 12,692 | +1.2% | 0.39% | -21.7% |
| Q2 2020 | $917,000 | +324.5% | 12,542 | +97.4% | 0.49% | +229.3% |
| Q1 2020 | $216,000 | – | 6,352 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |